In postmenopausal women, breast cancer is a common phenomenon, and it can be divided into invasive and non-invasive based on histopathological findings and can be treated based on their hormone receptor status (ER, PR, and HER2) [1]. Here, ERBB2 is linked to breast carcinoma.